Sunday 10 August 2008

PSA Dynamics And Nomograms In The Diagnosis And Treatment Planning For Prostate Cancer

�UroToday.com - The innovation of PSA as a marker for prostate crab has dramatically altered how prostate genus Cancer is diagnosed and treated. Along with the improvements in diagnosing and discourse options has come the realization that as workforce age prostate gland cancer is relatively usual and that not all prostate crab is fatal and needfully needs to be actively treated.


Almost as presently as PSA was introduced into widespread use, efforts were underway to increment diagnostic sensitivity and specificity, to place those populations of men who would benefit from screening and to tell intermediate and high risk of infection disease from the small risk diverseness. PSA can be elevated for a number of reasons and distinguishing benign from malignant elevations remains one of the most important areas of on-going research.


This presentation testament review the current options in consumption for improving the diagnostic accuracy of PSA and will include PSA-density, free and bound PSA, PSA-velocity and PSA doubling time. A give-and-take of which of these PSA based-options is nigh appropriate for specific situations will also undertaken.


In the brand diagnostic site the persona of PSA and its variants as a portent tool will also be reviewed as will diagnostic and prognostication nomograms.


Recent abstracts from the American Society of Clinical Oncology and the American Urological Association meetings will be reviewed and the attendant should experience a clear understanding of the use of these various modalities following this presentation.


Finally, the current options for prostatic biopsy and the benefits and problems with the expanded regimens ar discussed.


Presented by: Thomas Keane, MD, at the Masters in Urology Meeting - July 31, 2008 - August 2, 2008, Elbow Beach Resort, Bermuda

UroToday - the only urogenital medicine website with original mental object written by global urology key public opinion leaders actively engaged in clinical practice.


To access the latest urogenital medicine news releases from UroToday, go to:
www.urotoday.com


Copyright � 2008 - UroToday



More info